Sam Altman, CEO of OpenAI, is co-founding Merge Labs, a brain-computer interface startup, setting the stage for competition ...

Sam Altman backs Merge Labs, a brain-computer interface startup rivaling Neuralink. With $250M funding, it aims to merge ...

Sam Altman is preparing to co-found a new company funded by OpenAI that will go up against Elon Musk's Neuralink.

OpenAI CEO Sam Altman is in talks to co-found Merge Labs, a potential $850M brain–computer interface startup rivaling Elon ...

Merge Labs will compete with Elon Musk’s Neuralink, which is developing computer interface chips designed to be implanted in ...

The brain chip company that has drawn interest from Sam Altman and his artificial intelligence business OpenAI is exploring ...

Merge Labs is a new Neuralink rival developing brain-computer interfaces. If you’ve enjoyed Elon Musk’s ongoing beef with ...

Merge Labs venture comes after OpenAI boss Sam Altman said the race to embed AI in humans is ‘going to get a lot weirder’ ...

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting brain cells. Read more here.

The Financial Times reports today that OpenAI co-founder Sam Altman plans to invest in new brain-computer interface (BCI) venture Merge Labs.

The feud between OpenAI CEO Sam Altman and onetime cofounder Elon Musk may soon escalate with news that the former is ...

Merge Labs, which aims to develop brain-computer interfaces, is in early talks to raise $250 million at an $850 million valuation from investors including OpenAI, the Financial Times reported. Merge ...